# Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)

Study · id `cardio:ct-nct04566991` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04566991](<https://clinicaltrials.gov/study/NCT04566991>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04566991

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04566991. Randomized; double masking; primary purpose treatment. Start 2022-03-20 (actual); primary completion 2029-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04566991, source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)
- Started: 2022-03-20 (actual) (ClinicalTrials.gov record NCT04566991, source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT04566991, source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)
- Completion: 2029-10 (anticipated) (ClinicalTrials.gov record NCT04566991, source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT04566991, source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04566991-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)
- Acronym: DISH
- Condition: Aneurysmal Subarachnoid Hemorrhage
- Intervention (Drug): Deferoxamine
- Intervention (Drug): Placebo
- Lead sponsor: Aditya S. Pandey, MD
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)

## Provenance

Content hash: 846fcbaf43731613b88b450a6e7a449df3d133e02e0048a5fc6ddf5e2b1848ad
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
